Oberweis Asset Management »

Krystal Biotech shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.8M 43k 183.64
2024-03-31 $6.4M 36k 177.93

More positions owned by Oberweis Asset Management

Weatherford Intl Ordf (WFRD)
Constellium Se cl a (CSTM)
Sharkninja (SN)
Onto Innovation (ONTO)
Transmedics Group (TMDX)
Zeta Global Holdings Corp (ZETA)
Encompass Health Corp (EHC)
Credo Technology Group Holding (CRDO)
SkyWest (SKYW)
Clean Harbors (CLH)
Adma Biologics (ADMA)
Silicon Motion Technology (SIMO)
Camtek (CAMT)
Universal Display Corporation (OLED)
Oshkosh Corporation (OSK)

View all positions for Oberweis Asset Management

Top funds holding Krystal Biotech

FMR
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Redmile Group
Frazier Life Sciences Management
T. Rowe Price Associates
Dimensional Fund Advisors
Geode Capital Management
Jennison Associates
Hood River Capital Management
Goldman Sachs Group
Lord, Abbett & Co
Nuveen Asset Management

View all funds holding Krystal Biotech